Novavax announces proposed public offering; Can scientists turn rice into vaccine storage?;

> Novavax ($NVAX) intends to offer to sell $100 million of its common stock in an underwritten public offering. Release

> Astellas has submitted a marketing application for flu vaccine ASP7374 in Japan. Release

> Oncothyreon ($ONTY) and Celldex Therapeutics ($CLDX) will collaborate on a combination immunotherapy clinical trial. Release

> The PATH Malaria Vaccine Initiative has named C. Richter King as its R&D director. More

> The United Nations Foundation and Walgreens received an award from the Cause Marketing Forum for their "Get A Shot. Give A Shot" campaign, which provided 3 million vaccines to children in developing countries. Release

> Researchers have developed a patch to help overcome needle phobia so that vaccines can be delivered pain- and stress-free. More

> Wisconsin's FluGen has raised $3.4 million for a Phase I trial of its universal flu vaccine candidate. Report

And Finally... A team of scientists at the University of Tokyo is trying to convert rice into a cheap storage and effective delivery vehicle for vaccines. More

Suggested Articles

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

As a new coronavirus spreads, vaccine researchers have started work on candidates against the virus—and one could enter the clinic in a few months.

Merck's HPV vaccine Gardasil is delivering blockbuster sales as demand surges. But high demand has caused somewhat of a supply constraint.